TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bristol-Myers Squibb Norway AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
200,872
|
157,484
|
507,055 |
Financial expenses |
372
|
495
|
1,287 |
Earnings before taxes |
9,890
|
7,976
|
23,686 |
Total assets |
268,052
|
251,702
|
281,224 |
Current assets |
267,709
|
251,553
|
281,029 |
Current liabilities |
59,384
|
51,705
|
88,096 |
Equity capital |
208,668
|
199,997
|
193,128 |
- share capital |
1,000
|
800
![]() |
800 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
77.8%
|
79.5%
|
68.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
4.9%
|
5.1%
|
4.7% |
Return on assets (ROA) |
3.8%
|
3.4%
|
8.9% |
Current ratio |
450.8%
|
486.5%
|
319.0% |
Return on equity (ROE) |
4.7%
|
4.0%
|
12.3% |
Change turnover |
43,388
|
-349,571
|
23,918 |
Change turnover % |
28%
|
-69%
|
5% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.